These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21399389)

  • 1. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked adrenoleukodystrophy and primary adrenal insufficiency.
    Cappa M; Todisco T; Bizzarri C
    Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy.
    Terluk MR; Tieu J; Sahasrabudhe SA; Moser A; Watkins PA; Raymond GV; Kartha RV
    Neurotherapeutics; 2022 Apr; 19(3):1007-1017. PubMed ID: 35378685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening.
    Rajakumar HK; Coimbatore Sathyabal V; Nachiappan R; Krishnaswamy Vijayaramanujam S
    Degener Neurol Neuromuscul Dis; 2024; 14():75-83. PubMed ID: 38912366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adrenal insufficiency as part of X-linked adrenoleukodystrophy].
    Enikeeva SR; Chugunov IS; Kareva MA; Kurkina MV; Zakharova EY; Michailova SV; Bezlepkina OB; Peterkova VA; Mokrysheva NG
    Probl Endokrinol (Mosk); 2023 Dec; 70(3):83-92. PubMed ID: 39069776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine dysfunction in adrenoleukodystrophy.
    Engelen M; Kemp S; Eichler F
    Handb Clin Neurol; 2021; 182():257-267. PubMed ID: 34266597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.
    Kaur N; Singh J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38854155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomyeloneuropathy manifesting as adrenal insufficiency and bilateral lower extremity spastic paraplegia: A case report and literature review.
    Chen Y; Li D; Xu P; Zhang A; Chen X; Chen Y
    Medicine (Baltimore); 2024 Jan; 103(2):e36946. PubMed ID: 38215098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins: implications for adrenoleukodystrophy.
    Pillai BK; Jasuja R; Simard JR; Hamilton JA
    J Biol Chem; 2009 Nov; 284(48):33296-304. PubMed ID: 19801636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset adrenoleukodystrophy presenting with status epilepticus and psychosis.
    Mehta AM; Prabhu M; Krishnan G
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective.
    Prinzi J; Pasquali M; Hobert JA; Palmquist R; Wong KN; Francis S; De Biase I
    Int J Neonatal Screen; 2023 Nov; 9(4):. PubMed ID: 37987477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal Insufficiency in Peroxisomal Disorders: A Single Institution Case Series.
    Gagnon C; Hurst ACE; Ashraf AP
    Horm Res Paediatr; 2023; 96(4):439-445. PubMed ID: 36649687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases.
    Goyal A; Dubey N; Verma A; Agrawal A
    Curr Mol Med; 2024; 24(4):419-427. PubMed ID: 37165502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A historical look using virtual microscopy: the first case report of adrenomyeloneuropathy (AMN).
    Budka H
    Free Neuropathol; 2023 Jan; 4():. PubMed ID: 37915358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy.
    Granadeiro L; Zarralanga VE; Rosa R; Franquinho F; Lamas S; Brites P
    Brain; 2024 Apr; 147(4):1457-1473. PubMed ID: 38066620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of oleic acid against very long-chain fatty acid-induced apoptosis in peroxisome-deficient CHO cells.
    Ali H; Yamanishi M; Sunagawa K; Kumon M; Hasi RY; Aihara M; Kawakami R; Tanaka T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Apr; 1869(3):159452. PubMed ID: 38244676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leriglitazone: frustration and hope in adrenoleukodystrophy.
    Schöls L
    Lancet Neurol; 2023 Feb; 22(2):103-105. PubMed ID: 36681436
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report.
    Liu J; Wang X; Huang D; Qi Y; Xu L; Shao Y
    Medicine (Baltimore); 2024 Apr; 103(16):e37874. PubMed ID: 38640304
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.